APA (7th ed.) Citation

SS, J., JS, W., SM, C., L, L., JW, M., M, M., . . . BB, R. (2022). Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events. Pediatric blood & cancer, 69(12), e29986. https://doi.org/10.1002/pbc.29986

Chicago Style (17th ed.) Citation

SS, Jacobs, et al. "Longitudinal Use of Patient Reported Outcomes in Pediatric Leukemia and Lymphoma Reveals Clinically Relevant Symptomatic Adverse Events." Pediatric Blood & Cancer 69, no. 12 (2022): e29986. https://doi.org/10.1002/pbc.29986.

MLA (9th ed.) Citation

SS, Jacobs, et al. "Longitudinal Use of Patient Reported Outcomes in Pediatric Leukemia and Lymphoma Reveals Clinically Relevant Symptomatic Adverse Events." Pediatric Blood & Cancer, vol. 69, no. 12, 2022, p. e29986, https://doi.org/10.1002/pbc.29986.